NCT02199080

Brief Summary

The purpose of this study is to determine whether D-dimer dosage allow to exclude risk of intraatrial thrombus before performing an ablation of atrial fibrillation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,506

participants targeted

Target at P75+ for not_applicable atrial-fibrillation

Timeline
Completed

Started Jul 2014

Geographic Reach
1 country

37 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 24, 2014

Completed
4 days until next milestone

Study Start

First participant enrolled

July 28, 2014

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

February 15, 2019

Completed
Last Updated

October 30, 2023

Status Verified

October 1, 2023

Enrollment Period

1.4 years

First QC Date

July 22, 2014

Results QC Date

February 28, 2018

Last Update Submit

October 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Patients With Atrial Thrombus Diagnosed by Transoesophageal Ultrasound

    up to 48 hours before ablation

Secondary Outcomes (3)

  • CHADS2 Score

    48 hours before ablation

  • Risk Factors

    48 hours before ablation

  • Atrial Thrombus Exclusion (ATE) Score

    48 hours before ablation

Study Arms (1)

Atrial fibrillation

OTHER

D-dimer assay before ablation of atrial fibrillation

Other: D-dimer assay before ablation of atrial fibrillation

Interventions

Blood sample collection for D-dimers measurement

Atrial fibrillation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age\> 18 years.
  • Patients hospitalized for ablation of atrial fibrillation or symptomatic left flutter
  • Patient informed of the study

You may not qualify if:

  • Age \<18 years.
  • Patients under guardianship
  • Pregnant woman
  • Contraindication to transesophageal echocardiography
  • transesophageal echocardiography made in another center as the center of ablation
  • Refusal of the patient to participate in the study
  • Patient participating in another interventional study in which an intervention related to biomedical research is performed before the transesophageal echocardiography

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (37)

Service de cardiologie, CH de la Région d'Annecy

Annecy, France

Location

Centre Hospitalier d' Auxerre

Auxerre, France

Location

Service de cardiologie, CH Avignon

Avignon, France

Location

Clinique La Fourcade

Bayonne, France

Location

Service de cardiologie, CHU Bordeaux

Bordeaux, France

Location

Service de cardiologie, CHU Brest

Brest, France

Location

Service de cardiologie, CHU Caen

Caen, France

Location

Service de cardiologie, CHU Clermont Ferrand

Clermont-Ferrand, France

Location

Service de cardiologie, AP Hôpital Henri Mondor

Créteil, France

Location

Service de cardiologie, CHU Dijon

Dijon, France

Location

Groupe Hospitalier de la Rochelle Ré Aunis

La Rochelle, 17019, France

Location

Service de cardiologie, CH Le Mans

Le Mans, France

Location

Service de cardiologie, CHU Limoges

Limoges, France

Location

Service de cardiologie, HCL Groupement Est

Lyon, France

Location

Service de cardiologie, APM Hôpital de La Timone

Marseille, France

Location

Service de cardiologie, CHI Aix Pertuis CHPA-CHIAP

Marseille, France

Location

Service de cardiologie, Hôpital Saint Joseph

Marseille, France

Location

Service de cardiologie, Institut Jacques Cartier

Massy, France

Location

Service de cardiologie, CHR Metz Thionville

Metz, France

Location

Service de cardiologie, CHI Le Raincy Montfermeil

Montfermeil, France

Location

Service de cardiologie, CHU Nancy

Nancy, France

Location

Service de cardiologie, Nouvelles Cliniques Nantaises

Nantes, France

Location

Service de cardiologie, CHU Nîmes

Nîmes, France

Location

Service de cardiologie, HP Les Franciscaines

Nîmes, France

Location

Service de cardiologie, AP Hôpital la Pitié Salpêtrière

Paris, France

Location

Service de cardiologie, Groupe Hospitalier Bichat Claude Bernard

Paris, France

Location

Service de cardiologie, Institut Mutualiste Montsouris

Paris, France

Location

Service de cardiologie, CH Pau

Pau, France

Location

Service de cardiologie, CHU Poitiers

Poitiers, France

Location

Service de cardiologie, CHU Rennes

Rennes, France

Location

Service de cardiologie, CHU Rouen

Rouen, France

Location

Service de cardiologie, Centre Cardiologique du Nord

Saint-Denis, France

Location

Service de cardiologie, CHU Saint Etienne

Saint-Etienne, France

Location

Service de cardiologie, CHU Toulouse Hôtel Dieu St Jacques

Toulouse, France

Location

Service de cardiologie, Clinique Saint Gatien

Tours, France

Location

Service de cardiologie, Clinique Saint Joseph

Trélaze, France

Location

Service de cardiologie, Polyclinique Vauban

Valenciennes, France

Location

Related Publications (1)

  • Milhem A, Ingrand P, Treguer F, Cesari O, Da Costa A, Pavin D, Rivat P, Badenco N, Abbey S, Zannad N, Winum PF, Mansourati J, Maury P, Bader H, Savoure A, Sacher F, Andronache M, Allix-Beguec C, De Chillou C, Anselme F; ATE Study Group. Exclusion of Intra-Atrial Thrombus Diagnosis Using D-Dimer Assay Before Catheter Ablation of Atrial Fibrillation. JACC Clin Electrophysiol. 2019 Feb;5(2):223-230. doi: 10.1016/j.jacep.2018.09.009. Epub 2018 Nov 1.

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr Antoine Milhem
Organization
Groupe Hospitalier de la Rochelle Ré Aunis

Study Officials

  • Antoine MILHEM, MD

    Groupe Hospitalier de la Rochelle Ré Aunis

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2014

First Posted

July 24, 2014

Study Start

July 28, 2014

Primary Completion

January 1, 2016

Study Completion

May 1, 2016

Last Updated

October 30, 2023

Results First Posted

February 15, 2019

Record last verified: 2023-10

Locations